MEF2C and Fabry disease: Lee et al. went on to identify kinetin as a candidate drug to rescue aberrant IKBKAP splicing, while Kim et al. shed light on a previously unknown aspect of FD pathogenesis- aberrant splicing in other genes such as PAX3 and MEF2C in FD iNCCs.